drugset / Trial / NCT03867240

Gabapentin and Chronic Post Surgical Pain

NCT03867240 ↗

Phase 3 Withdrawn Emory University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the effect of a common pain medication (gabapentin) on chronic postsurgical pain in pediatric patients who require surgery for idiopathic scoliosis.

Timeline

Start
2019-06
Primary completion
2022-09
Completion
2022-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study initially suspended recruitment due to COVID-19. Study withdrawn due to PI leaving institution in early 2021.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Unknown 100 mg —
Subject Gabapentin Unknown 200 mg —